This paper presents the findings and recommendations of the 2026 CSR. Drawing on staff reviews of Article IV staff reports and multilateral surveillance reports, analysis, and consultations with internal and external stakeholders, the CSR assesses the experience since the 2021 review and sets strategic and operational priorities for strengthening surveillance over the next 5–10 years.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: